TCL Archive Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate. October 10, 2008
TCL Archive In Brief: Henney To Leave NCI For Kansas; Dan Longo Heads BRMP; DeVita To Receive Nervi Award May 10, 1985
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs June 20, 1975
TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant June 11, 2014
